""clinicaltrials.gov is a US based website and the obvious lack of easy designation has resulted in the change you noted. In our case (but not only in our case) the different regulatory authorities apply slightly different classifications.""
Therefore no clinical error, and the information the site contains is FDA imposed.
"" As data is available from CAN-003, this can validate the confirmatory nature of CANVAS""
We have had interim data and now we are a Phase 2 ???????
Hope things improve.
The above is not my doing as you would believe reading this PRR thread, just trying to highlight the basics to help people make an informed decision.....thanks anyway.
""clinicaltrials.gov is a US based website and the obvious lack...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 53192 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 41048 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |